Is Lyme disease more prominent in certain states?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Geographic Distribution of Lyme Disease in the United States

Lyme disease is highly concentrated in specific states, with the northeastern, mid-Atlantic, and upper north-central regions accounting for approximately 90-93% of all U.S. cases. 1, 2, 3

Highest Risk States

Connecticut has the highest reported state incidence of Lyme disease in the United States, with 70 cases per 100,000 population documented in 1997. 4, 2 The disease is not uniformly distributed across the country but rather shows marked geographic clustering:

  • Ten states account for 93% of all reported cases: Connecticut, Delaware, Massachusetts, Maryland, Minnesota, New Jersey, New York, Pennsylvania, Rhode Island, and Wisconsin 3
  • Approximately 90% of cases occur in roughly 140 counties concentrated along the northeastern and mid-Atlantic seaboard 2
  • The highest county-level incidence was 600 cases per 100,000 population in Nantucket County, Massachusetts 4

Regional Patterns

Northeastern United States

The northeastern region represents the epicenter of Lyme disease transmission, where optimal ecological conditions exist for the primary vector tick Ixodes scapularis and its reservoir hosts. 1, 2 In highly endemic northeastern areas like Connecticut, 15-30% of blacklegged tick nymphs carry Borrelia burgdorferi, creating substantial transmission risk. 2

North-Central States

Minnesota and Wisconsin represent the second major endemic focus, with both Borrelia burgdorferi sensu stricto and the more recently identified Borrelia mayonii reported in 10 counties across these states. 1, 5

Western United States

California has limited Lyme disease transmission despite the presence of vector ticks, with cases primarily occurring in northern and north-coastal regions. 1, 5 The western vector Ixodes pacificus is far less efficient at disease transmission than the northeastern I. scapularis. 2

Emerging Geographic Trends

The geographic distribution of Lyme disease is actively expanding due to ecological and environmental changes. 1 Recent surveillance data demonstrates:

  • North Carolina has experienced rapid emergence of Lyme disease in northwestern regions along the Appalachian Mountains, with some zip codes now reporting incidence rates similar to historically high-incidence northeastern states 6
  • The spatial distribution of cases has become increasingly clustered over time, with Moran's I increasing from 0.012 (p=0.127) in 2010-2012 to 0.403 (p<0.0001) in 2019-2020 in North Carolina 6
  • Annual case counts increased 101% from 9,908 cases in 1992 to 19,931 cases in 2006 nationally 3

Within-State Variation

Risk varies dramatically not only between states but within counties and townships. 4 Even in high-incidence states, the probability of Lyme disease can vary by as much as 30-fold based on specific residential location. 7 In Maryland, for example, the probability of Lyme disease is greatest north and west of Baltimore, with substantial local variation. 7

Critical Pitfall to Avoid

Clinicians must avoid assuming all tick bites carry equal Lyme disease risk, as geographic variation is profound. 2 Connecticut has 20-30 times higher risk than southern states like Texas based on available data. 2 Additionally, a rash similar to erythema migrans but NOT caused by B. burgdorferi has been described in southern states like Texas, associated with Amblyomma americanum tick bites, which can lead to misdiagnosis. 2

Practical Recommendations

For accurate risk assessment, detailed information regarding the distribution of Lyme disease risk within specific areas is best obtained from state and local public health authorities rather than relying solely on state-level data. 4

References

Guideline

Causative Agent and Epidemiology of Lyme Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lyme Disease Prevalence and Epidemiology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Surveillance for Lyme disease--United States, 1992-2006.

Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002), 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.